Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Carisma Therapeutics And Ocugen Subsidiary, OrthoCellix, Enter All-Stock Merger Agreement; Carisma Will Issue To The Pre-Merger OrthoCellix Stockholder Shares Of Carisma Common Stock As Merger Consideration In Exchange For The Cancellation Of Shares Of Capital Stock Of OrthoCellix

Author: Benzinga Newsdesk | June 23, 2025 07:42am

Posted In: CARM OCGN